• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于糖尿病酮症酸中毒的哈特曼氏溶液与0.9%生理盐水的对照试验。

Controlled trial of Hartmann's solution versus 0.9% saline for diabetic ketoacidosis.

作者信息

Yung Michael, Letton Georgia, Keeley Steve

机构信息

Department of Paediatric Critical Care, Women's and Children's Hospital, Adelaide, South Australia, Australia.

出版信息

J Paediatr Child Health. 2017 Jan;53(1):12-17. doi: 10.1111/jpc.13436.

DOI:10.1111/jpc.13436
PMID:28070957
Abstract

AIM

We aimed to determine whether using a balanced salt solution, Hartmann's solution (HS), in diabetic ketoacidosis (DKA) shortens the time to normalise acid-base status through the avoidance of hyperchloremic metabolic acidosis compared with 0.9% normal saline (NS).

METHODS

We conducted a double-blind, randomised controlled trial comparing HS to NS as the initial intravenous fluid in children with DKA. Patients were stratified by severity (pH < 7.1) and known or new diabetes. Electrolytes, venous blood gases and glucose were measured every 2 h until intravenous fluids were ceased. The primary outcome was the time for the plasma bicarbonate to reach 15 mmol/L. Secondary outcomes included time to normalise pH (7.3), time to receive subcutaneous (SC) insulin, change in sodium and insulin requirement.

RESULTS

A total of 77 children were enrolled. The groups were similar at baseline. There was no difference in the time to reach a bicarbonate of 15 mmol/L: geometric mean (SD) 8.6 (2.3) h for NS versus 6.2 (4.7) h for HS, ratio 1.4 (95% confidence interval 0.8-2.5), and no difference in time to normalise pH: NS 8.5 (2.3) h versus HS group 7.5 (1.8) h, ratio 1.1 (0.8-1.6). Kaplan-Meier survival estimates showed shorter times for these end-points in the severe subgroup: log-rank test P = 0.0277 and 0.0024, respectively. There was no difference in time to SC insulin, NS: 15.2 (2.4) h versus HS 14.3 (1.6) h, ratio 1.1 (0.8-1.5). Patients treated with HS received significantly less total fluids/kg.

CONCLUSIONS

HS is an acceptable alternative to NS in DKA and may benefit those with severe DKA.

摘要

目的

我们旨在确定在糖尿病酮症酸中毒(DKA)中,与0.9%生理盐水(NS)相比,使用平衡盐溶液哈特曼氏溶液(HS)是否可通过避免高氯性代谢性酸中毒来缩短酸碱状态恢复正常的时间。

方法

我们进行了一项双盲随机对照试验,比较HS与NS作为DKA患儿的初始静脉输液。患者按严重程度(pH < 7.1)以及已知或新发糖尿病进行分层。每2小时测量电解质、静脉血气和血糖,直至停止静脉输液。主要结局是血浆碳酸氢盐达到15 mmol/L的时间。次要结局包括pH恢复正常(7.3)的时间、开始皮下注射(SC)胰岛素的时间、钠的变化以及胰岛素需求量。

结果

共纳入77名儿童。两组在基线时相似。达到碳酸氢盐15 mmol/L的时间无差异:NS组几何均数(标准差)为8.6(2.3)小时,HS组为6.2(4.7)小时,比值为1.4(95%置信区间0.8 - 2.5);pH恢复正常的时间也无差异:NS组为8.5(2.3)小时,HS组为7.5(1.8)小时,比值为1.1(0.8 - 1.6)。Kaplan-Meier生存估计显示,在严重亚组中这些终点的时间较短:对数秩检验P值分别为0.0277和0.0024。开始SC胰岛素治疗的时间无差异:NS组为15.2(2.4)小时,HS组为14.3(1.6)小时,比值为1.1(0.8 - 1.5)。接受HS治疗的患者每千克体重接受的总液体量显著更少。

结论

在DKA中,HS是NS的可接受替代方案,并可能使重度DKA患者受益。

相似文献

1
Controlled trial of Hartmann's solution versus 0.9% saline for diabetic ketoacidosis.用于糖尿病酮症酸中毒的哈特曼氏溶液与0.9%生理盐水的对照试验。
J Paediatr Child Health. 2017 Jan;53(1):12-17. doi: 10.1111/jpc.13436.
2
0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.0.9%生理盐水与 Plasma-Lyte 作为糖尿病酮症酸中毒患儿的初始液体(SPinK 试验):一项双盲随机对照试验。
Crit Care. 2020 Jan 2;24(1):1. doi: 10.1186/s13054-019-2683-3.
3
Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis: A Subgroup Analysis of Cluster Randomized Clinical Trials.糖尿病酮症酸中毒成人中平衡晶体液与生理盐水的临床效果:集群随机临床试验的亚组分析。
JAMA Netw Open. 2020 Nov 2;3(11):e2024596. doi: 10.1001/jamanetworkopen.2020.24596.
4
Fluid management in diabetic-acidosis--Ringer's lactate versus normal saline: a randomized controlled trial.糖尿病酸中毒中的液体管理——林格氏乳酸盐与生理盐水:一项随机对照试验。
QJM. 2012 Apr;105(4):337-43. doi: 10.1093/qjmed/hcr226. Epub 2011 Nov 22.
5
Effect of normal saline and half normal saline on serum electrolytes during recovery phase of diabetic ketoacidosis.生理盐水和半量生理盐水对糖尿病酮症酸中毒恢复期血清电解质的影响。
J Intensive Care Med. 2014 Jan-Feb;29(1):38-42. doi: 10.1177/0885066612467149. Epub 2012 Nov 19.
6
Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.皮下注射门冬胰岛素治疗糖尿病酮症酸中毒
Diabetes Care. 2004 Aug;27(8):1873-8. doi: 10.2337/diacare.27.8.1873.
7
Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial.严重糖尿病酮症酸中毒(SCOPE-DKA)中氯化钠或 Plasmalyte-148 的评估:一项集群、交叉、随机、对照试验。
Intensive Care Med. 2021 Nov;47(11):1248-1257. doi: 10.1007/s00134-021-06480-5. Epub 2021 Oct 5.
8
A randomised controlled trial of Hartmann's solution versus half normal saline in postoperative paediatric spinal instrumentation and craniotomy patients.哈特曼溶液与半生理盐水在小儿脊柱器械和颅切开术后随机对照试验。
Arch Dis Child. 2012 Jun;97(6):491-6. doi: 10.1136/archdischild-2011-300221. Epub 2012 Jan 30.
9
Utilizing serum bicarbonate instead of venous pH to transition from intravenous to subcutaneous insulin shortens the duration of insulin infusion in pediatric diabetic ketoacidosis.在儿科糖尿病酮症酸中毒中,使用血清碳酸氢盐而非静脉血pH值来从静脉胰岛素转换为皮下胰岛素,可缩短胰岛素输注时间。
J Pediatr Endocrinol Metab. 2019 Jan 28;32(1):11-17. doi: 10.1515/jpem-2018-0394.
10
Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis.静脉内碳酸氢钠治疗严重酸中毒的糖尿病酮症酸中毒。
Ann Pharmacother. 2013 Jul-Aug;47(7-8):970-5. doi: 10.1345/aph.1S014. Epub 2013 Jun 4.

引用本文的文献

1
Reevaluating potassium supplementation in pediatric DKA: Is routine KPO use necessary?重新评估儿童糖尿病酮症酸中毒中的钾补充:常规使用磷酸钾是否必要?
J Endocrinol Invest. 2025 Aug 18. doi: 10.1007/s40618-025-02686-2.
2
0.9% Saline versus Ringer's lactate as initial fluid in children with diabetic ketoacidosis: a double-blind randomized controlled trial.0.9%生理盐水与乳酸林格氏液作为糖尿病酮症酸中毒患儿初始补液的比较:一项双盲随机对照试验
BMJ Open Diabetes Res Care. 2025 Apr 7;13(2):e004623. doi: 10.1136/bmjdrc-2024-004623.
3
Normal Saline Versus Ringer's Lactate for Intravenous Fluid Therapy in Children with Diabetic Ketoacidosis: A Randomized Controlled Trial.
糖尿病酮症酸中毒患儿静脉补液治疗中生理盐水与乳酸林格氏液的比较:一项随机对照试验
Indian J Pediatr. 2024 Sep 20. doi: 10.1007/s12098-024-05240-9.
4
Comparison of balanced crystalloids versus normal saline in patients with diabetic ketoacidosis: a meta-analysis of randomized controlled trials.平衡晶体液与生理盐水在糖尿病酮症酸中毒患者中的比较:一项随机对照试验的荟萃分析。
Front Endocrinol (Lausanne). 2024 May 21;15:1367916. doi: 10.3389/fendo.2024.1367916. eCollection 2024.
5
Evaluation of a Protocol Change Promoting Lactated Ringers Over Normal Saline in the Treatment of Diabetic Ketoacidosis.评估一项将乳酸林格氏液替代生理盐水用于治疗糖尿病酮症酸中毒的方案变更。
J Diabetes Sci Technol. 2024 May;18(3):549-555. doi: 10.1177/19322968241235941. Epub 2024 Mar 7.
6
Comparing the clinical effects of balanced electrolyte solutions versus normal saline in managing diabetic ketoacidosis: A systematic review and meta-analyses.比较平衡电解质溶液与生理盐水治疗糖尿病酮症酸中毒的临床效果:一项系统评价和荟萃分析。
Turk J Emerg Med. 2023 Jun 26;23(3):131-138. doi: 10.4103/tjem.tjem_355_22. eCollection 2023 Jul-Sep.
7
ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children- a systematic review and meta-analysis.ESPNIC 临床实践指南:急性和危重症儿童的静脉维持液疗法——系统评价和荟萃分析。
Intensive Care Med. 2022 Dec;48(12):1691-1708. doi: 10.1007/s00134-022-06882-z. Epub 2022 Oct 26.
8
[Analysis of the variables involved in the time to resolution of metabolic parameters in adults with diabetic ketoacidosis].[成人糖尿病酮症酸中毒代谢参数恢复时间相关变量分析]
Rev Fac Cien Med Univ Nac Cordoba. 2022 Sep 16;79(3):223-227. doi: 10.31053/1853.0605.v79.n3.34968.
9
Normal Saline Versus Low Chloride Solutions in Treatment of Diabetic Ketoacidosis: A Systematic Review of Clinical Trials.生理盐水与低氯溶液治疗糖尿病酮症酸中毒:临床试验的系统评价
Cureus. 2022 Jan 17;14(1):e21324. doi: 10.7759/cureus.21324. eCollection 2022 Jan.
10
Saline Compared to Balanced Crystalloid in Patients With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.糖尿病酮症酸中毒患者中生理盐水与平衡晶体液的比较:随机对照试验的系统评价和荟萃分析
Crit Care Explor. 2022 Jan 6;4(1):e0613. doi: 10.1097/CCE.0000000000000613. eCollection 2022 Jan.